Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

17.09
-1.2300-6.71%
Post-market: 17.600.5100+2.98%19:04 EST
Volume:1.16M
Turnover:19.98M
Market Cap:1.57B
PE:-6.08
High:18.57
Open:18.44
Low:16.81
Close:18.32
52wk High:19.16
52wk Low:5.15
Shares:91.71M
Float Shares:75.46M
Volume Ratio:1.43
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8108
EPS(LYR):-4.9960
ROE:-93.04%
ROA:-46.48%
PB:5.94
PE(LYR):-3.42

Loading ...

Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025

GlobeNewswire
·
Oct 27

Craig-Hallum Reaffirms Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Oct 24

Immunome presents preclinical data on ADC payload HC74

TIPRANKS
·
Oct 24

Immunome Unveils Preclinical Data Showing HC74 ADC Payload Overcomes Drug Resistance in Cancer Models

Reuters
·
Oct 24

Immunome Inc. Grants Stock Options to New Employees Under 2024 Inducement Plan

Reuters
·
Oct 03

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Oct 03

Immunome (IMNM) Gets a Buy from Evercore ISI

TIPRANKS
·
Sep 24

Leerink Partners Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Sep 24

Immunome’s Promising Oncology Pipeline and Strong Market Potential Justify Buy Rating

TIPRANKS
·
Sep 24

Immunome Initiated at Buy by Goldman Sachs

Dow Jones
·
Sep 22

Goldman Sachs Initiates Immunome at Buy With $26 Price Target

MT Newswires Live
·
Sep 22

Immunome announces novel antibody collaboration with Infinimmune

TIPRANKS
·
Sep 18

Infinimmune Announces Research Collaboration With Immunome

THOMSON REUTERS
·
Sep 18

Infinimmune: Financial Terms of Deal Were Not Disclosed

THOMSON REUTERS
·
Sep 18

Evercore ISI Reaffirms Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Sep 18

Immunome (IMNM) Gets a Buy from Guggenheim

TIPRANKS
·
Sep 15

Immunome Initiated at Buy by Craig-Hallum

Dow Jones
·
Sep 05

Craig-Hallum Initiates Immunome at Buy With $26 Price Target

MT Newswires Live
·
Sep 05

Immunome Inc. Announces Inducement Grants of Stock Options to New Employees Under 2024 Plan

Reuters
·
Sep 05

Immunome Price Target Maintained With a $25.00/Share by Guggenheim

Dow Jones
·
Aug 25